Ticker > Company >

TruAlt Bioenergy share price

TruAlt Bioenergy Ltd.

NSE: TRUALT BSE: 544545 SECTOR: Breweries & Distilleries  559   0   1

530.95
+34.95 (7.05%)
NSE: 03 Oct 04:11 PM

Price Summary

Today's High

₹ 549

Today's Low

₹ 512.8

52 Week High

₹ 549

52 Week Low

₹ 512.8

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

4553.03 Cr.

Enterprise Value

5937.65 Cr.

No. of Shares

8.58 Cr.

P/E

32.38

P/B

2.84

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  187.17

CASH

147.83 Cr.

DEBT

1532.45 Cr.

Promoter Holding

-

EPS (TTM)

₹  16.4

Sales Growth

54.48%

ROE

31.61 %

ROCE

13.87%

Profit Growth

306.27 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year54.48%
3 Year∞%
5 YearNA

Profit Growth

1 Year306.27%
3 Year2152.86%
5 YearNA

ROE%

1 Year31.61%
3 Year46.47%

ROCE %

1 Year13.87%
3 Year12.45%

Debt/Equity

1.9966

Price to Cash Flow

13.57

Interest Cover Ratio

2.0788

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Investors List
 Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 46.471% over the past 3 years.
  • Company’s PEG ratio is 0.100734441674661.
  • The company has an efficient Cash Conversion Cycle of 9.31909999999999 days.

 Limitations

  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0 762.38 1217.08 1880.12
Total Expenditure 0.01 657.33 1029.33 1582.92
Operating Profit -0.01 105.05 187.75 297.19
Other Income 0 0 56.35 60.59
Interest 0 35.31 141.01 141.04
Depreciation 0 20.75 55.78 64.6
Exceptional Items 0 0 0 0
Profit Before Tax -0.01 48.99 47.3 152.15
Tax 0 13.53 12.69 11.54
Net Profit -0.01 35.46 34.61 140.62
Adjusted EPS (Rs.) -2.02 5.33 4.71 19.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.06 207.98 207.98 70.63
Total Reserves -0.01 32.52 61.18 696.9
Borrowings 0 1070.33 954.35 1102.86
Other N/C liabilities 0 102.62 105.35 85.95
Current liabilities 0.01 442.53 1034.31 1021.41
Total Liabilities 0.06 1855.98 2363.17 2977.76
Assets
Net Block 0 1301.58 1370.51 1771.77
Capital WIP 0 9.62 201.25 2.78
Intangible WIP 0 0 0 0
Investments 0 0 16.92 16.92
Loans & Advances 0 76.48 131.7 137.48
Other N/C Assets 0 4.2 0.55 1.53
Current Assets 0.06 464.1 642.24 1047.29
Total Assets 0.06 1855.98 2363.17 2977.76
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -0.01 48.99 47.3 152.15
Adjustment 0 56.31 196.81 193.29
Changes in Assets & Liabilities 0.01 128.19 -211.81 -12.2
Tax Paid 0 0 -3.97 2.26
Operating Cash Flow 0 233.49 28.33 335.5
Investing Cash Flow 0 -1148.58 -388.82 -256.99
Financing Cash Flow 0.06 919.81 373.09 51.94
Net Cash Flow 0.06 4.72 12.6 130.45

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

TruAlt Bioenergy Stock Price Analysis and Quick Research Report. Is TruAlt Bioenergy an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse TruAlt Bioenergy. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). TruAlt Bioenergy has a PE ratio of 32.379343570479 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. TruAlt Bioenergy has ROA of 5.2656% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. TruAlt Bioenergy has a Current ratio of 1.0253.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. TruAlt Bioenergy has a ROE of 31.6063%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. TruAlt Bioenergy has a Debt to Equity ratio of 1.9966 which means that the company has low proportion of debt in its capital.

  • Sales growth: TruAlt Bioenergy has reported revenue growth of 54.4777% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of TruAlt Bioenergy for the current financial year is 15.8072004683114%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for TruAlt Bioenergy is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of TruAlt Bioenergy is Rs 16.3978. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of TruAlt Bioenergy in Ticker for free. Also, one can get the intrinsic value of TruAlt Bioenergy by using Valuation Calculators, which are available with a Finology ONE subscription. 

TruAlt Bioenergy FAQs

Q1. What is TruAlt Bioenergy share price today?
Ans: The current share price of TruAlt Bioenergy is Rs 530.95.

Q2. What is the market capitalisation of TruAlt Bioenergy?
Ans: TruAlt Bioenergy has a market capitalisation of Rs 4553.033819145 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of TruAlt Bioenergy?
Ans: The PE ratio of TruAlt Bioenergy is 32.379343570479 and the P/B ratio of TruAlt Bioenergy is 2.83675931436925, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of TruAlt Bioenergy share?
Ans: The 52-week high share price of TruAlt Bioenergy is Rs 549, and the 52-week low share price of TruAlt Bioenergy is Rs 512.8.

Q5. Does TruAlt Bioenergy pay dividends?
Ans: Currently, TruAlt Bioenergy does not pay dividends. Dividend yield of TruAlt Bioenergy is around 0%.

Q6. What are the face value and book value of TruAlt Bioenergy shares?
Ans: The face value of TruAlt Bioenergy shares is Rs 10, while the book value per share of TruAlt Bioenergy is around Rs 187.1678. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of TruAlt Bioenergy?
Ans: TruAlt Bioenergy has a total debt of Rs 1532.4472 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of TruAlt Bioenergy?
Ans: The ROE of TruAlt Bioenergy is 31.6063% and ROCE of TruAlt Bioenergy is 13.8742%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is TruAlt Bioenergy a good buy for the long term?
Ans: The TruAlt Bioenergy long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is TruAlt Bioenergy undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the TruAlt Bioenergy appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check TruAlt Bioenergy’s financials?
Ans: You can review TruAlt Bioenergy’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about TruAlt Bioenergy

TruAlt Bioenergy Share Price, Company Overview & IPO Details

TruAlt Bioenergy, one of India's largest ethanol producers, made a positive debut on the stock market on October 3, 2025. The TruAlt Bioenergy share price listed at Rs 545.40 on the NSE, a premium of 9.96% over its IPO issue price of Rs 496. On the BSE, the stock began trading at Rs 550, a premium of 10.89%.

About TruAlt Bioenergy Ltd.

Founded in 2021, TruAlt Bioenergy is a major player in India's biofuel sector, primarily focused on ethanol production. The company is among the largest ethanol producers in the country based on installed capacity.

Key Business Highlights

  • Significant Production Capacity: As of fiscal year 2025, the company operated five distillery units in Karnataka with an aggregate installed capacity of 2,000 kilolitres per day (KLPD), accounting for about 3.6% of India's domestic ethanol production capacity.

  • Diversified Bioenergy Portfolio: Beyond ethanol, the company has diversified into Compressed Biogas (CBG) through its subsidiary, Leafiniti, which is one of the first producers under the government's SATAT scheme. TruAlt also has plans to expand into second-generation (2G) ethanol and Sustainable Aviation Fuel (SAF).

  • Strategic Shift: To mitigate risks associated with the price and availability of raw materials like sugar syrup and molasses, the company is strategically shifting its focus towards producing grain-based ethanol.

TruAlt Bioenergy IPO & Listing Performance (September-October 2025)

The IPO of TruAlt Bioenergy, which was open from September 25 to September 29, 2025, was one of the most sought-after issues of the year, receiving a massive subscription of nearly 72 times.

  • Listing Price (NSE): Rs 545.40 (9.96% premium)

  • Listing Price (BSE): Rs 550 (10.89% premium)

  • IPO Price Band: Rs 472 – Rs 496 per share

  • Issue Size: Rs 839.28 crore (Fresh issue of Rs 750 crore + OFS of Rs 89.28 crore)

  • Subscription Status: The issue was heavily oversubscribed, with the Qualified Institutional Buyer (QIB) portion booked over 165 times and the Non-Institutional Investor (NII) portion over 103 times.

The listing, while positive, was below the estimates from the grey market, which had indicated a potential premium of around 17%.

Use of IPO Proceeds

The net proceeds from the fresh issue component of the IPO are intended to be used for:

  • Setting up grain-based ethanol capacity at one of its units in Karnataka.

  • Supporting working capital requirements.

  • General corporate purposes.

Financial Highlights

TruAlt Bioenergy has demonstrated rapid growth in its financials. For the fiscal year ending March 31, 2025, the company reported:

  • Revenue: Rs 1,969 crore, a 54% year-on-year increase.

  • Net Profit: Rs 147 crore, a nearly five-fold jump from Rs 32 crore in the previous year.

  • Valuation: At the upper end of the price band, the company was valued at approximately 29 times its fiscal year 2025 earnings.

What You Can Find on This Company Page

This page is your complete resource for all information related to TruAlt Bioenergy Ltd. Here’s what you can access:

  • Live TruAlt Bioenergy Share Price: Track real-time price movements and analyse historical performance with charts.

  • IPO and Listing Details: Get all the information about the IPO, including the price band, subscription details, and listing day performance.

  • In-Depth Financial Analysis: Access detailed financial statements and key ratios.

  • Shareholding Pattern: Get a clear picture of the company's ownership structure.

  • Latest News and Corporate Actions: Stay informed about the latest company announcements and other market-moving news.

Frequently Asked Questions (FAQs) about TruAlt Bioenergy Share Price

Q1: What was the listing price of TruAlt Bioenergy?
The shares listed at Rs 545.40 on the NSE and Rs 550 on the BSE, a premium of about 10-11% over the IPO price of Rs 496.

Q2: How was the investor response to the TruAlt Bioenergy IPO?
The IPO was oversubscribed nearly 72 times, showing massive demand, especially from institutional investors.

Q3: What does TruAlt Bioenergy do?
The company is one of India's largest producers of ethanol and is diversifying into other biofuels like Compressed Biogas (CBG).

Q4: What was the issue size of the TruAlt Bioenergy IPO?
The IPO was a mix of a fresh issue and an Offer for Sale, aggregating to Rs 839.28 crore.

Read More
X